Interventions for preventing the progression of autosomal dominant polycystic kidney disease

Medicine and Dentistry

• ACE Inhibitor 50%
• Adverse Event 50%
• Albuminuria 16%
• All Cause Mortality 16%
• Amaurosis 16%
• Analysis 16%
• Angiotensin Receptor Antagonist 33%
• Antiplatelet Drug 33%
• Aptitude 16%
• Beta Adrenergic Receptor Blocking Agent 33%
• Calcium Channel Blocking Agent 33%
• Cardiovascular System 16%
• Cellular Mechanism 16%
• Child 16%
• Clinical Management 16%
• Complication 16%
• Comprehension 16%
• Diarrhea 33%
• Diastolic Blood Pressure 16%
• Disease Exacerbation 33%
• Growth 16%
• Hypertension 16%
• Icosapentaenoic Acid 33%
• Infection 16%
• Intention-to-Treat Analysis 16%
• Kidney Function 66%
• Kidney Structure 33%
• Language 16%
• Mammalian Target of Rapamycin Inhibitor 33%
• Meta-Analysis 16%
• Nephropathy 16%
• Pathogenesis 16%
• Patient 66%
• Polycystic Kidney Disease 100%
• Progressive Disease 16%
• Quality of Life 16%
• Randomized Controlled Trial 16%
• Somatostatin Derivative 33%
• Statin 33%
• Sudden Death 16%
• Symptom 16%
• Therapeutic Procedure 50%
• Thirst 16%
• Vasopressin V2 Receptor 16%
• Vitamin D 33%
• Xerostomia 16%